BioSpace News Archive

The presentation will take place on Tuesday, January 14, 2020 at 12:00 p.m. PT at the Westin St. Francis in San Francisco.

AngioDynamics, Inc., a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, announced financial results for the second quarter of fiscal year 2020, which ended November 30, 2019.

ABB, FANUC, Kawasaki Robotics, Rethink Robotics, Techman Robot and Universal Robots Emerge as Companies to Watch in This Segment

Marinus Pharmaceuticals, Inc., announced that Dr. Scott Braunstein, Chief Executive Officer, will present a corporate overview at the 38th Annual J.P. Morgan Global Healthcare Conference on Thursday, January 16, 2020 at 11:00am Pacific Time.

Biocon Ltd (BSE code: 532523, NSE: BIOCON), an innovation-led global biopharmaceuticals company, today announced that the Board of its subsidiary Biocon Biologics India Ltd (Biocon Biologics) has approved a primary equity investment by True North.

Context Therapeutics announced that chief executive officer Martin Lehr will deliver a corporate presentation at Biotech Showcase™ 2020, being held January 13-15, 2020, at the Hilton San Francisco Union Square in San Francisco.

CEL-SCI Corporation, a Phase 3 cancer immunotherapy company, announced the full exercise of the over-allotment option granted to the underwriters with respect to 90,959 additional shares of common stock, in connection with its previously announced underwritten public offering of 606,395 million shares, bringing total gross proceeds from the offering to approximately $6.325 million.

Inspire Medical Systems, Inc. announced that its management team will be presenting at the 38th Annual J.P. Morgan Healthcare Conference on January 16, 2020 at the Westin St. Francis Hotel in San Francisco.

Twenty-two innovation pioneers were announced as the National Inventors Hall of Fame® 2020 class of Inductees on stage at CES®.

Danaher Corporation announced that it will webcast its quarterly earnings conference call for the fourth quarter 2019 on Thursday, January 30, 2020 beginning at 8:00 a.m. ET and lasting approximately 1 hour..